• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD MEDICAL - DIABETES CARE SYRINGE 0.3ML 31GA 8MM TW 10BAG 500 CA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD MEDICAL - DIABETES CARE SYRINGE 0.3ML 31GA 8MM TW 10BAG 500 CA Back to Search Results
Catalog Number 320440
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Code Available (3191)
Event Date 10/01/2019
Event Type  Injury  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that foreign matter occurred after use with a bd vacutainer® push button blood collection set with pre-attached holder.The following information was provided by the initial reporter."it was reported that a case of silicone bubbles post avastin injection was confirmed.Event description per attached email states: fyi: we have just confirmed another case of silicone bubbles post avastin injection.Injection date was oct (b)(6).The pt is booked for ongoing intraocular injections, right eye.We do not have the lot # of the syringes." 1 of 2 complaints.
 
Manufacturer Narrative
Correction: b.5.Describe event or problem: it was reported that foreign matter occurred after use with a syringe 0.3ml 31ga 8mm tw 10bag 500 ca.The following information was provided by the initial reporter, "it was reported that a case of silicone bubbles post avastin injection was confirmed.Event description per attached email states: fyi: we have just confirmed another case of silicone bubbles post avastin injection.Injection date was oct 1/19.The pt is booked for ongoing intraocular injections, right eye.We do not have the lot # of the syringes." 1 of 2 complaints.H.6.Investigation summary: no samples (including photos) were returned therefore the complaint could not be confirmed and the root cause is undetermined.Complaints received for this device and reported condition will continue to be tracked and trended.If samples are received in the future the complaint will be reopened for further investigation.A review of the device history record was completed for batch# 9070598.All inspections and challenges were performed per the applicable operations qc specifications.There was one (1) notification(b)(4) silicone outer diameter of barrel.There were two (2) notifications(b)(4) noted that did not pertain to the complaint.As no samples and/or photo(s) were received the investigation concluded: -unconfirmed: bd was not able to duplicate or confirm the customer¿s indicated failure as no samples or photos were returned.Based on the above, no additional investigation and no capa is required at this time.It is important to note bd only markets insulin delivery syringes for subcutaneous use.Consistent with the naming convention and scale marking of an insulin syringe, it is insulin-specific, and it is approved by health canada for the intended use of subcutaneous injection of insulin.Insulin scale mark gradations are in insulin units as opposed to ml found on general purpose syringes.Bd does not intend for its insulin syringes to be used for any purpose other than subcutaneous injection of insulin.H3 other text : see section h.10.
 
Event Description
It was reported that foreign matter occurred after use with a bd vacutainer® push button blood collection set with pre-attached holder.The following information was provided by the initial reporter."it was reported that a case of silicone bubbles post avastin injection was confirmed.Event description per attached email states: fyi: we have just confirmed another case of silicone bubbles post avastin injection.Injection date was (b)(6) 2019.The pt is booked for ongoing intraocular injections, right eye.We do not have the lot # of the syringes.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYRINGE 0.3ML 31GA 8MM TW 10BAG 500 CA
Type of Device
SYRINGE
Manufacturer (Section D)
BD MEDICAL - DIABETES CARE
1329 west highway 6
holdrege NE 68949
MDR Report Key9324639
MDR Text Key166593866
Report Number1920898-2019-01295
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 12/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date03/31/2024
Device Catalogue Number320440
Device Lot Number9070598
Initial Date Manufacturer Received 10/30/2019
Initial Date FDA Received11/14/2019
Supplement Dates Manufacturer Received10/30/2019
Supplement Dates FDA Received12/09/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-